Polygon Management
Latest statistics and disclosures from Tetragon Partners GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PATH, KGEI, AUTL, LYFT, DFTX, and represent 65.12% of Tetragon Partners GP's stock portfolio.
- Added to shares of these 10 stocks: PATH (+$62M), ALKT (+$11M), RLAY (+$7.3M), CELC (+$6.7M), SLN, IONS, DFTX, AGIO, MBX, HRMY.
- Started 6 new stock positions in TENX, GLUE, ALKT, ACRS, CUE, CELC.
- Reduced shares in these 10 stocks: WBD (-$18M), PRAX (-$5.1M), AXSM, Soleno Therapeutics, MPLT, AARD, NKTR, CLDX, ANNX, AMLX.
- Sold out of its positions in AARD, MPLT, PRAX, Soleno Therapeutics.
- Tetragon Partners GP was a net buyer of stock by $93M.
- Tetragon Partners GP has $635M in assets under management (AUM), dropping by 23.29%.
- Central Index Key (CIK): 0001515070
Tip: Access up to 7 years of quarterly data
Positions held by Polygon Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tetragon Partners GP
Tetragon Partners GP holds 36 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 53.0 | $336M | +22% | 31M | 10.87 |
|
| Kolibri Global Energy Com New (KGEI) | 5.3 | $34M | 6.8M | 4.95 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 2.4 | $15M | 9.5M | 1.60 |
|
|
| Lyft Cl A Com (LYFT) | 2.3 | $15M | 1.0M | 14.61 |
|
|
| Definium Therapeutics Com Shs (DFTX) | 2.1 | $14M | +43% | 287k | 47.04 |
|
| Workiva Com Cl A (WK) | 1.9 | $12M | 250k | 48.51 |
|
|
| Silence Therapeutics Ads Call Option (SLN) | 1.8 | $12M | +68% | 1.1M | 10.98 |
|
| Sprinklr Cl A (CXM) | 1.8 | $11M | 2.2M | 5.16 |
|
|
| Mbx Biosciences (MBX) | 1.8 | $11M | +39% | 204k | 55.20 |
|
| Alkami Technology (ALKT) | 1.7 | $11M | NEW | 600k | 18.12 |
|
| Celldex Therapeutics Com New (CLDX) | 1.7 | $11M | -7% | 290k | 37.21 |
|
| Relay Therapeutics (RLAY) | 1.7 | $11M | +214% | 570k | 18.71 |
|
| Arrowhead Pharmaceuticals (ARWR) | 1.7 | $11M | +2% | 131k | 81.51 |
|
| Pharvaris N V (PHVS) | 1.6 | $10M | +33% | 296k | 34.58 |
|
| Alkermes SHS (ALKS) | 1.6 | $10M | +18% | 190k | 52.40 |
|
| Immunovant (IMVT) | 1.6 | $9.9M | +17% | 256k | 38.53 |
|
| Agios Pharmaceuticals (AGIO) | 1.5 | $9.5M | +55% | 256k | 37.11 |
|
| Axsome Therapeutics Call Option (AXSM) | 1.3 | $8.6M | -36% | 35k | 244.77 |
|
| Dyne Therapeutics (DYN) | 1.2 | $7.9M | +38% | 357k | 22.21 |
|
| Ionis Pharmaceuticals (IONS) | 1.2 | $7.7M | +132% | 97k | 79.29 |
|
| Harmony Biosciences Hldgs In (HRMY) | 1.2 | $7.3M | +68% | 201k | 36.41 |
|
| Krystal Biotech (KRYS) | 1.2 | $7.3M | 20k | 371.67 |
|
|
| Annexon (ANNX) | 1.1 | $7.1M | -3% | 1.2M | 5.71 |
|
| Celcuity (CELC) | 1.1 | $6.7M | NEW | 64k | 104.62 |
|
| Warner Bros Discovery Com Ser A (WBD) | 1.0 | $6.7M | -72% | 250k | 26.66 |
|
| Nektar Therapeutics Com New (NKTR) | 1.0 | $6.1M | -15% | 87k | 69.81 |
|
| Amylyx Pharmaceuticals Call Option (AMLX) | 0.9 | $5.5M | -3% | 306k | 17.96 |
|
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $4.2M | +16% | 168k | 25.30 |
|
| Ultragenyx Pharmaceutical Call Option (RARE) | 0.5 | $3.3M | +153% | 100k | 33.39 |
|
| Cue Biopharma (CUE) | 0.5 | $3.0M | NEW | 94k | 31.56 |
|
| Snowflake Com Shs (SNOW) | 0.4 | $2.5M | 10k | 254.50 |
|
|
| Karyopharm Therapeutics Com New Call Option (KPTI) | 0.4 | $2.4M | +143% | 250k | 9.77 |
|
| Aclaris Therapeutics (ACRS) | 0.3 | $2.1M | NEW | 400k | 5.29 |
|
| Tectonic Therapeutic (TECX) | 0.3 | $1.6M | +23% | 47k | 34.38 |
|
| Monte Rosa Therapeutics (GLUE) | 0.2 | $1.4M | NEW | 56k | 24.20 |
|
| Tenax Therapeutics Com New Call Option (TENX) | 0.2 | $1.1M | NEW | 75k | 14.55 |
|
Past Filings by Tetragon Partners GP
SEC 13F filings are viewable for Tetragon Partners GP going back to 2012
- Tetragon Partners GP 2026 Q2 filed Aug. 13, 2026
- Tetragon Partners GP 2026 Q1 filed May 15, 2026
- Tetragon Partners GP 2025 Q4 filed Feb. 17, 2026
- TFG Asset Management GP 2025 Q3 filed Nov. 14, 2025
- TFG Asset Management GP 2025 Q2 filed Aug. 14, 2025
- TFG Asset Management GP 2025 Q1 filed May 15, 2025
- TFG Asset Management GP 2024 Q4 restated filed Feb. 21, 2025
- TFG Asset Management GP 2024 Q4 filed Feb. 14, 2025
- TFG Asset Management GP 2024 Q3 filed Nov. 14, 2024
- TFG Asset Management GP 2024 Q2 filed Aug. 14, 2024
- TFG Asset Management GP 2024 Q1 filed May 15, 2024
- TFG Asset Management GP 2023 Q4 filed Feb. 14, 2024
- TFG Asset Management GP 2023 Q3 filed Nov. 14, 2023
- TFG Asset Management GP 2023 Q2 filed Aug. 14, 2023
- TFG Asset Management GP 2023 Q1 filed May 15, 2023
- TFG Asset Management GP 2022 Q4 filed Feb. 14, 2023